Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

OOnKure Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
O

OnKure Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 21, 2026Saccomano Nicholas APresident and CEO87Class A Common Stock$256.65Sell
Sep 21, 2026Leverone Jason A.Chief Financial Officer302Class A Common Stock$890.90Sell
Aug 7, 2026Mathers Edward TDirector22,350Stock Option (right to buy)$92.5KGrant / award
Aug 7, 2026GREY MICHAEL GDirector22,350Stock Option (right to buy)$92.5KGrant / award
Aug 7, 2026Ratcliffe LiamDirector22,350Stock Option (right to buy)$92.5KGrant / award
Aug 7, 2026Saccomano Nicholas APresident and CEO542,232Employee Stock Option (right to buy)$2.2MGrant / award
Aug 7, 2026Saccomano Nicholas APresident and CEO542,232Employee Stock Option (right to buy)$2.2MOther
Aug 7, 2026Saccomano Nicholas APresident and CEO25,347Employee Stock Option (right to buy)$104.9KGrant / award
Aug 7, 2026Saccomano Nicholas APresident and CEO25,347Employee Stock Option (right to buy)$104.9KOther
Aug 7, 2026Saccomano Nicholas APresident and CEO1,485Employee Stock Option (right to buy)$6.1KGrant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
$3.10Close · Sep 22, 2026